Manufacture

Scientists use computationally designed imitation antibodies to fight the flu – and production costs.

Medicine packaging leaders forming the “Matrix Alliance” will bring improved container and closure systems to market.

The combination of genomic profiling and high-tech targeted drug delivery is opening up a new front in the fight against cancer.

Translating medicine packaging information for international markets is a major challenge.

Regulators come down hard on facilities that come up short.

The UK Competition and Markets Authority (CMA) has handed out a £37.6 million fine to GSK for paying out “value transfers totaling over 50 million pounds” to competitors between 2001 and 2004 to delay the introduction of generic versions of its branded anti-depressant drug, Seroxat (paroxetine).

Chemists solve a 46-year- old problem to develop a new drug modification method.

The western world could be considered king of the biotech jungle, but eager biopharma tigers from the east are hungry for a piece of the action – and they are gaining ground. Can single-use technologies help them to catch up even faster? Jinghui Xu believes so.

Although the discussion about the use of preservatives is still somewhat controversial, clinical evidence suggests that patients benefit from unpreserved eye drops especially in chronic conditions.

Engineered cell therapies hold exciting potential for the pharmaceutical industry – but only if contract manufacturing organizations and vendors play their part in the revolution.